未登录

M

Mauro Andreotti

istituto superiore di sanita (iss)

H指数:27

被引数:2,494

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SARS-CoV-2-Specific CD8+ T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection

感染后接种疫苗的K18-hACE2小鼠血液中SARS-CoV-2-Specific的CD8 T细胞，但肺部没有

IF3.4

2023-08-301

OAAI

Micronutrient and Nutritional Status of HIV-Exposed and HIV-Unexposed Malawian Infants in the First Year of Life: Assessment of Ferritin, Vitamin A, and D Status and Its Association with Growth

IF5

2023-07-240

OAAI

Rates of Seroprotection against Vaccine-Preventable Infectious Diseases in HIV-Exposed and -Unexposed Malawian Infants

IF3.3

2023-07-140

OAAI

Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles

IF6.5

2023-06-027

OAAI

Immunoglobulin G passive transfer from mothers to infants: total IgG, IgG subclasses and specific antipneumococcal IgG in 6-week Malawian infants exposed or unexposed to HIV

BMC INFECTIOUS DISEASES

IF3

2022-04-053

OAAI

Transcriptome Profiling of Human Monocyte-Derived Macrophages Upon CCL2 Neutralization Reveals an Association Between Activation of Innate Immune Pathways and Restriction of HIV-1 Gene Expression

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-09-1811

OAAI

In vivo antiaging effects of alkaline water supplementation

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2020-02-2712

OAAI

Beneficial Effects of Fermented Papaya Preparation (FPP®) Supplementation on Redox Balance and Aging in a Mouse Model

IF6.6

2020-02-0714

OAAI

Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion

BMC BIOTECHNOLOGY

IF3.4

2019-10-1720

OAAI

Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure

IF3.1

2019-10-0117

OAAI

APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz

FRONTIERS IN IMMUNOLOGY

IF5.9

2018-08-088

OAAI

Deficit of IgG2 in HIV-positive pregnant women is responsible of inadequate IgG2 levels in their HIV-uninfected children in Malawi

MEDICAL MICROBIOLOGY AND IMMUNOLOGY

IF3

2018-02-273

PREAI

Antibody response to hepatitis B vaccine in HIV-exposed infants in Malawi and correlation with HBV infection acquisition

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2018-02-265

PREAI

High CMV IgG antibody levels are associated to a lower CD4+RESPONSE to antiretroviral therapy in HIV-infected women

JOURNAL OF CLINICAL VIROLOGY

IF3.4

2017-11-016

PREAI

Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique

CLINICAL INFECTIOUS DISEASES

IF7.3

2017-07-2343

OAAI

Cytomegalovirus (CMV) DNA load in breast milk of human immunodeficiency virus-positive women and infant CMV infection acquisition are not reduced with long-term antiretroviral therapy

CLINICAL MICROBIOLOGY AND INFECTION

IF8.5

2017-07-012

OAAI

Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients

IMMUNITY INFLAMMATION AND DISEASE

IF2.7

2017-04-2071

OAAI

Hepatitis E virus infection in HIV-infected pregnant women and their children in Malawi

INFECTIOUS DISEASES

IF2.3

2017-04-085

PREAI

CMV infection in a cohort of HIV-exposed infants born to mothers receiving antiretroviral therapy during pregnancy and breastfeeding

MEDICAL MICROBIOLOGY AND IMMUNOLOGY

IF3

2016-09-157

PREAI

Levels of bone markers in a population of infants exposed in utero and during breastfeeding to tenofovir within an Option B plus programme in Malawi

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2016-07-118

OAAI